SEC Info - Universal Health Services Inc - ‘10-K’ for 12/31/10

SEC Info℠

Home

Help

Please Sign In

Universal Health Services Inc – ‘10-K’ for 12/31/10 – ‘XML.R11’

On: Monday, 2/28/11, at 5:02pm ET · For: 12/31/10 · Accession #: 1193125-11-50142 · File #: 1-10765

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/11  Universal Health Services Inc     10-K       12/31/10   39:7.5M                                   Donnelley … Solutions/FA

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Universal Health Services Inc--Form 10-K            HTML   1.84M 
 2: EX-10.3     Agreement                                           HTML     15K 
 3: EX-21       Subsidiaries of Registrant                          HTML    107K 
 4: EX-23.1     Consent of Independent Registered Accounting Firm   HTML     14K 
 5: EX-31.1     Section 302 CEO Certification                       HTML     17K 
 6: EX-31.2     Section 302 CFO Certification                       HTML     17K 
 7: EX-32.1     Section 906 CEO Certification                       HTML     14K 
 8: EX-32.2     Section 906 CFO Certification                       HTML     14K 
31: XML         IDEA XML File -- Definitions and References          XML     97K 
36: XML         IDEA XML File -- Filing Summary                      XML     85K 
34: XML.R1      Document and Entity Information                      XML    324K 
35: XML.R2      Consolidated Statements of Income                    XML    400K 
22: XML.R3      Consolidated Statements of Income (Parenthetical)    XML     36K 
26: XML.R4      Consolidated Balance Sheets                          XML    671K 
30: XML.R5      Consolidated Balance Sheets (Parenthetical)          XML    291K 
29: XML.R6      Consolidated Statements of Changes in Equity         XML   1.76M 
38: XML.R7      Consolidated Statements of Changes in Equity         XML     85K 
                (Parenthetical)                                                  
18: XML.R8      Consolidated Statements of Cash Flows                XML    550K 
28: XML.R9      Business and Summary of Significant Accounting       XML    151K 
                Policies                                                         
17: XML.R10     Acquisitions and Divestitures                        XML     92K 
16: XML.R11     Financial Instruments                                XML     44K 
21: XML.R12     Long-Term Debt                                       XML     72K 
33: XML.R13     Common Stock                                         XML    152K 
23: XML.R14     Income Taxes                                         XML    148K 
24: XML.R15     Lease Commitments                                    XML     60K 
27: XML.R16     Commitments and Contingencies                        XML     73K 
39: XML.R17     Relationship With Universal Health Realty Income     XML     57K 
                Trust and Related Party Transactions                             
19: XML.R18     Pension Plan                                         XML    180K 
15: XML.R19     Segment Reporting                                    XML     78K 
25: XML.R20     Quarterly Results                                    XML    134K 
32: XML.R21     Schedule Ii-Valuation and Qualifying Accounts        XML     52K 
37: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    855K 
 9: EX-101.INS  XBRL Instance -- uhs-20101231                        XML   1.21M 
11: EX-101.CAL  XBRL Calculations -- uhs-20101231_cal                XML    134K 
12: EX-101.DEF  XBRL Definitions -- uhs-20101231_def                 XML    157K 
13: EX-101.LAB  XBRL Labels -- uhs-20101231_lab                      XML    449K 
14: EX-101.PRE  XBRL Presentations -- uhs-20101231_pre               XML    301K 
10: EX-101.SCH  XBRL Schema -- uhs-20101231                          XSD     55K 
20: ZIP         XBRL Zipped Folder -- 0001193125-11-050142-xbrl      Zip    104K

‘XML.R11’ — Financial Instruments

This Financial Report is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

<ReportLongName> 10301 - Disclosure - FINANCIAL INSTRUMENTS </ReportLongName>

<ShowElementNames> false </ShowElementNames>

<HasEmbeddedReports> false </HasEmbeddedReports>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<LabelColumn> false </LabelColumn>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

<MCU>

<KeyName> 1/1/2010 - 12/31/2010 USD ($) USD ($) / shares </KeyName>

<ContextID> Duration_1_1_2010_To_12_31_2010 </ContextID>

<PeriodType> duration </PeriodType>

</contextRef>

<UPS>

<UnitType> Standard </UnitType>

</StandardMeasure>

</UnitProperty>

<UnitType> Standard </UnitType>

<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>

<MeasureValue> shares </MeasureValue>

<MeasureNamespace> xbrli </MeasureNamespace>

</StandardMeasure>

</UnitProperty>

<UnitType> Divide </UnitType>

</NumeratorMeasure>

<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>

<MeasureValue> shares </MeasureValue>

<MeasureNamespace> xbrli </MeasureNamespace>

</DenominatorMeasure>

</UnitProperty>

</UPS>

</MCU>

</Labels>

</Column>

</Columns>

<Rows>

<Row>

<ElementName> uhs_FinancialInstrumentsAbstract </ElementName>

<IsBaseElement> false </IsBaseElement>

<PeriodType> duration </PeriodType>

<ShortDefinition> Financial Instruments [Abstract] </ShortDefinition>

<IsReportTitle> false </IsReportTitle>

<IsSegmentTitle> false </IsSegmentTitle>

<IsSubReportEnd> false </IsSubReportEnd>

<IsCalendarTitle> false </IsCalendarTitle>

<IsTuple> false </IsTuple>

<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>

<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>

<IsBeginningBalance> false </IsBeginningBalance>

<IsEndingBalance> false </IsEndingBalance>

<IsReverseSign> false </IsReverseSign>

<Cells>

<Cell>

<IsNumeric> false </IsNumeric>

<IsRatio> false </IsRatio>

<DisplayZeroAsNone> false </DisplayZeroAsNone>

<IsIndependantCurrency> false </IsIndependantCurrency>

<ShowCurrencySymbol> false </ShowCurrencySymbol>

<DisplayDateInUSFormat> false </DisplayDateInUSFormat>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

</Cell>

</Cells>

<Unit> Other </Unit>

<ElementDataType> xbrli:stringItemType </ElementDataType>

<SimpleDataType> string </SimpleDataType>

<ElementDefenition> Financial Instruments [Abstract] </ElementDefenition>

<IsTotalLabel> false </IsTotalLabel>

<IsEPS> false </IsEPS>

<Label> FINANCIAL INSTRUMENTS </Label>

</Row>

<Row>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<ElementName> us-gaap_FairValueMeasurementInputsDisclosureTextBlock </ElementName>

<PeriodType> duration </PeriodType>

<ShortDefinition> No definition available. </ShortDefinition>

<IsReportTitle> false </IsReportTitle>

<IsSegmentTitle> false </IsSegmentTitle>

<IsSubReportEnd> false </IsSubReportEnd>

<IsCalendarTitle> false </IsCalendarTitle>

<IsTuple> false </IsTuple>

<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>

<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>

<IsBeginningBalance> false </IsBeginningBalance>

<IsEndingBalance> false </IsEndingBalance>

<IsReverseSign> false </IsReverseSign>

<PreferredLabelRole> terselabel </PreferredLabelRole>

<Cells>

<Cell>

<IsNumeric> false </IsNumeric>

<IsRatio> false </IsRatio>

<DisplayZeroAsNone> false </DisplayZeroAsNone>

<div> 3) FINANCIAL INSTRUMENTS Fair Value Hedges: During 2010, 2009, and 2008, we had no fair value hedges outstanding. Cash Flow Hedges: Our interest expense is sensitive to changes in the general level of interest rates. To mitigate the impact of fluctuations in domestic interest rates, a portion of our debt is fixed rate accomplished by either borrowing on a long-term basis at fixed rates or by, from time to time, entering into interest rate swap and interest rate cap transactions. Interest rate swap agreements require us to pay fixed and receive floating interest rates or to pay floating and receive fixed interest rates over the life of the agreements. Interest rate caps provide for us to receive a payment for each quarter the 3-month LIBOR exceeds a given strike price. We may also, from time to time, enter into treasury locks ("T-Locks") to protect from a rise in the yield of the underlying treasury security for a forecasted bond issuance. Effective January 1, 2009, we adopted the authoritative guidance for disclosures in connection with derivative instruments and hedging activities which requires additional disclosure about a company's derivative activities, but does not require any new accounting related to derivative activities. We have applied the requirements of the guidance on a prospective basis. Accordingly, disclosures related to interim periods prior to the date of adoption have not been presented. During the fourth quarter of 2010, we entered into three interest rate caps on a total notional amount of $1 billion whereby we paid a premium of $240,000 in exchange for the counterparties agreeing to pay the difference between 2.25% and three-month LIBOR if the 3 month LIBOR rate rises above 2.25% during the term of the caps. If the three month LIBOR does not reach 2.25% during the term of the caps, no payment is made to us. All of the caps expire on December 15, 2011. We also entered into four forward starting interest rate swaps in the fourth quarter of 2010 whereby we pay a fixed rate on a total notional amount of $600 million and receive 3-month LIBOR. Each of the four swaps become effective on December 15, 2011 and will mature on May 15, 2015. The average fixed rate payable on these swaps is 2.38%. During the fourth quarter of 2007, we entered into two interest rate swaps whereby we pay a fixed rate on a total notional principal amount of $150 million and receive 3-month LIBOR. Each of the two interest rate swaps has a notional principal amount of $75 million. The fixed rate payable on the first interest rate swap is 4.7625% and matures on October 5, 2012. The fixed rate payable on the second interest rate swap is 4.865% and the maturity date is October, 17, 2011. The notional amount of the second interest rate swap reduced to $50 million on October 18, 2010. We measure our interest rate swaps at fair value on a recurring basis. The fair value of our interest rate swaps is based primarily on quotes from banks. We consider those inputs to be "level 3" in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with derivative instruments and hedging activities. The fair value of our interest rate swaps was a liability of $10 million at December 31, 2010, of which $2 million is included in other current liabilities and $8 million is included in other noncurrent liabilities on the accompanying balance sheet. The fair value of our interest rate swaps was $12 million as of December 31, 2009 which is included in other noncurrent liabilities. </div>

</NonNumbericText>

<NonNumericTextHeader> 3) FINANCIAL INSTRUMENTS Fair Value Hedges: During 2010, 2009, and 2008, we had no fair value hedges outstanding. Cash Flow Hedges: Our </NonNumericTextHeader>

<IsIndependantCurrency> false </IsIndependantCurrency>

<ShowCurrencySymbol> false </ShowCurrencySymbol>

<DisplayDateInUSFormat> false </DisplayDateInUSFormat>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

</Cell>

</Cells>

<Unit> Other </Unit>

<ElementDataType> us-types:textBlockItemType </ElementDataType>

<SimpleDataType> string </SimpleDataType>

<ElementDefenition> This element represents the disclosure related to the fair value measurement of assets and liabilities which includes [financial] instruments measured at fair value that are classified in stockholders' equity. Such assets and liabilities may be measured on a recurring or nonrecurring basis. The disclosures which may be required or desired include: (1) for assets and liabilities measured on a recurring basis, disclosure may include: (a) the fair value measurements at the reporting date; (b) the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3); (c) for fair value measurements using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (ii) purchases, sales, issuances, and settlements (net); (iii) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs); (d) the amount of the total gains or losses for the period in subparagraph (c) (i) above included in earnings (or changes in net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of where those unrealized gains or losses are reported in the statement of income (or activities); (e) the valuation technique(s) used to measure fair value and a discussion of changes in valuation techniques, if any, during the period and (2) for assets and liabilities that are measured at fair value on a nonrecurring basis (for example, impaired assets) disclosure may include, in addition to (a) above: (a) the reasons for the fair value measurements recorded; (b) the same as (b) above; (c) for fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used to develop the inputs; and (d) the valuation technique(s) used to measure fair value and a discussion of changes, if any, in the valuation technique(s) used to measure similar assets and/or liabilities in prior periods. </ElementDefenition>

<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 32 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 33 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 157 -Paragraph 6 -Footnote 4 </ElementReferences>

<IsTotalLabel> false </IsTotalLabel>

<IsEPS> false </IsEPS>

<Label> FINANCIAL INSTRUMENTS </Label>

</Row>

</Rows>

<ReportName> FINANCIAL INSTRUMENTS </ReportName>

<MonetaryRoundingLevel> UnKnown </MonetaryRoundingLevel>

<SharesRoundingLevel> UnKnown </SharesRoundingLevel>

<PerShareRoundingLevel> UnKnown </PerShareRoundingLevel>

<ExchangeRateRoundingLevel> UnKnown </ExchangeRateRoundingLevel>

<HasCustomUnits> false </HasCustomUnits>

</InstanceReport>

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/20/11  SEC                               UPLOAD¶     9/21/17    1:45K  Universal Health Services Inc.
 8/09/11  SEC                               UPLOAD¶     9/21/17    1:50K  Universal Health Services Inc.
 7/06/11  SEC                               UPLOAD¶     9/21/17    1:61K  Universal Health Services Inc.

↑Top

Filing Submission 0001193125-11-050142 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Universal Health Services Inc – ‘10-K’ for 12/31/10 – ‘XML.R11’

On: Monday, 2/28/11, at 5:02pm ET · For: 12/31/10 · Accession #: 1193125-11-50142 · File #: 1-10765

Previous ‘10-K’: ‘10-K’ on 2/25/10 for 12/31/09 · Next: ‘10-K/A’ on 9/8/11 for 12/31/10 · Latest: ‘10-K’ on 2/27/24 for 12/31/23 · 3 References: By: SEC – ‘UPLOAD’ on 9/20/11 By: SEC – ‘UPLOAD’ on 8/9/11 By: SEC – ‘UPLOAD’ on 7/6/11

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘XML.R11’ — Financial Instruments

This Financial Report is an XBRL XML File.

3 Subsequent Filings that Reference this Filing

Previous ‘10-K’: ‘10-K’ on 2/25/10 for 12/31/09 · Next: ‘10-K/A’ on 9/8/11 for 12/31/10 · Latest: ‘10-K’ on 2/27/24 for 12/31/23 · 3 References:

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents